Upstate Active Clinical Trials Seeking Participants
A 12-month, randomized, rater- and dose-blinded study to compare the efficacy and safety of fingolimod 0.25 mg and 0.5 mg administered orally once daily with glatiramer acetate 20 mg administered subcutaneously once daily in patients with relapsing-remitting multiple sclerosis
What is the purpose of the study?
Compare 2 doses of fingolimod to copaxone and to evaluate the efficacy and safety of fingolimod for the treatment of patients with relapsing-remitting Multiple Sclerosis
Who is eligible?
Male or Female patients 18 to 65 years of age with relapsing-remitting Multiple Sclerosis
What is involved if I participate?
- How long is the study?
- Is transportation provided or reimbursed?
- Is parking provided or reimbursed?
- What tests and procedures are involved?
MRI, Neurological assessments and safety assessments.
Who is the doctor administering the study?
Burk Jubelt, MD
Where will the study take place?
Institute for Human Performance
Over what time period is the study scheduled to run?
6/2013 - 2/2016
Who can I contact for more information?
- Name: Andrea McGlond
- Phone: 315-464-6409
- Email: McglondA@upstate.edu
If you are interested in this trial, please contact the study coordinator or investigator noted above.